
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform global - The Economic Times
4baseCare is a precision oncology startup that develops genomics-driven cancer diagnostics and AI-powered clinical decision support tools. The company aims to make precision oncology more inclusive for under-represented populations by decentralizing genomic testing infrastructure and expanding its services globally. With a focus on addressing gaps in population-relevant genomic data, 4baseCare is working to enable more personalized cancer treatment.
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform global The Economic Times

| Jun 11, 2026 | $480K | — | India | |
| Jun 11, 2026 | FirstClub Technology | $55.0M | Series B | India |
| Jun 11, 2026 | Manam Chocolate | $9.0M | Series A | India |
| Jun 11, 2026 | QubeHealth-Pay | $50.0M | Series A | India |